We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

636:HKEXKLN Logistics Group Limited Analysis

Data as of 2026-06-02 - not real-time

¥705.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Chiyoda Corp is trading at ¥705, well below its DCF‑derived fair value of roughly ¥1,408, indicating a modest upside of about 7 %. The stock’s price‑to‑earnings multiple sits at 8.7, dramatically lower than the industry average of 29.8, underscoring a clear valuation discount. However, revenue has contracted by 4.7 % YoY and free cash flow is negative, raising concerns about sustainable earnings growth. Technical signals are mixed: the 20‑day SMA (≈¥810) sits above the current price, the 14‑day RSI is at 34 % (suggesting the stock is oversold), and the MACD histogram has turned slightly positive, hinting at a tentative bullish shift. Volume is on a decreasing trend, and 30‑day volatility is high at over 80 %, reflecting a choppy market environment. The company carries a low debt load (debt‑to‑equity ≈19 %) and a strong cash position, but the negative free cash flow and modest ROE (≈1.2 %) limit confidence in long‑term cash generation. The Fear & Greed Index reads “Extreme Greed,” indicating market optimism that may be disconnected from fundamentals. Overall, the stock appears undervalued on a price basis but faces earnings and cash‑flow headwinds, suggesting a cautious yet opportunistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in oversold territory (~34)
  • Price hovering near support (~¥685)
  • Bullish MACD histogram despite high volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Low PE relative to industry peers
  • Improving technical momentum

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative free cash flow and modest ROE
  • Cyclical nature of engineering & construction sector
  • Limited upside beyond ~7 % from current price

Key Metrics & Analysis

Financial Health

Revenue Growth-4.70%
Profit Margin17.14%
P/E Ratio8.7
ROE120.48%
ROA10.53%
Debt/Equity19.33
P/B Ratio1.6
Op. Cash Flow¥26.1B
Free Cash Flow¥-46799876096
Industry P/E29.8

Technical Analysis

TrendNeutral
RSI34.3
Support¥685.00
Resistance¥1,059.00
MA 20¥810.00
MA 50¥957.90
MA 200¥772.92
MACDBullish
VolumeDecreasing
Fear & Greed Index92.77

Valuation

Fair Value¥1,407.98
Target Price¥756.67
Upside/Downside7.33%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.00
Volatility80.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.